PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Towards a better understanding of endothelial cell transformation in cancer progression

Towards a better understanding of endothelial cell transformation in cancer progression
2024-02-07
(Press-News.org) In a new study, Tokyo Medical and Dental University researchers shed light on partial endothelial-to-mesenchymal transition in the tumor microenvironment

Tokyo, Japan - Endothelial-mesenchymal transition (EndoMT, also termed as EndMT), a biological process resulting in the formation of mesenchymal (or lineage-committed) phenotypes from endothelial cells (lining blood vessels), plays a crucial role in tumor progression. Despite the important role of EndoMT, the underlying mechanism and characteristics of cells in intermediate/partial EndoMT remain largely unexplored. Now, researchers from Japan have developed a system to study these EndoMT stages. 

In a study published recently in Cancer Science, researchers from Tokyo Medical and Dental University (TMDU), Japan, report a system that can detect the intermediate and full stages of EndoMT. Named “EndoMT Reporter Endothelial Cells (EMRECs),” this novel reporter cell experimental system enables the visualization of the sequential changes that occur during EndoMT induced by transforming growth factor-β (TGF-β). TGF-β is a cytokine found abundantly in the tumor microenvironment (TME) and is known to play a key role in EndoMT. 

“In the present study, we established EMRECs to be able to visualize EndoMT transition in real-time and identified specific genes expressed in partial EndoMT during diseases like cancer,” explains the lead author of the study, Dr. Kazuki Takahashi.

To visualize the intermediate stages of EndoMT, the researchers developed an EndoMT-reporter transgenic mouse that expressed a red fluorescent protein under the control of an endothelial cell-specific marker and a green fluorescent protein under the control of α-smooth muscle actin (αSMA), a mesenchymal cell marker. Cells of endothelial lineage derived from this transgenic mouse would emit red fluorescence, providing insight into the endothelial lineage. EMRECs were established using immortalized endothelial cells from the transgenic mouse liver. Once EMRECs acquired mesenchymal cell characteristics, they would emit green fluorescence due to the expression of αSMA—a mesenchymal cell marker—resulting in a gradient change from orange to yellow, as cells express both the endothelial-lineage and mesenchymal markers. In addition, simultaneous detection of the expression of the endothelial cell marker ‘vascular endothelial growth factor receptor 2 (VEGFR2)’ in EMRECs can provide a more detailed understanding of the EndoMT sequential stages: the full EndoMT stage would no longer express VEGFR2, but the partial EndoMT stages with both endothelial and mesenchymal properties would still express VEGFR2. 

Quantitative RT-PCR (qRT-PCR) and immunohistochemical analyses of EMRECs revealed that treatment with TGF-β increased the expression of αSMA and lowered the expression of VEGFR2, indicating that EMRECs underwent TGF-β-induced EndoMT. Also, inhibition of TGF-β signaling in a human oral cancer xenograft mouse model reduced the ratio of cells expressing both endothelial and mesenchymal markers (indicating EndoMT) in tumors, suggesting that TGF-β inhibition suppresses EndoMT.

To observe the sequential changes of gene expression during EndoMT, the researchers cultured EMRECs with and without TGF-β treatment and used cell sorting assays to specifically pick up cells in stages of partial EndoMT, along with cells that underwent full EndoMT. 

Furthermore, by performing RNA sequencing analysis and comparing the cell population of each EndoMT stage, they identified CD40, a surface receptor involved in inflammation, which could serve as a potential partial EndoMT marker, highlighting its crucial role in studying the EndoMT mechanism. Elaborating further, senior author Dr. Miho Kobayashi remarks, “Interestingly and for the first time, our results have revealed CD40 as a potential partial EndoMT-specific marker. This is because high CD40 levels were observed in partial EndoMT cell population, but low levels were observed in endothelial and full EndoMT cell populations. We were further intrigued that CD40 suppressed the transition from partial to full EndoMT.” 

The team also validated tumor tissue samples from 226 patients across 10 solid cancer types by single-cell RNA sequencing analysis and found that the EndoMT pathway results in the formation of cancer-associated fibroblasts (CAFs) through CD40-positive partial EndoMT. CAFs are known to contribute to cancer progression and metastasis.

Adding further, senior author Dr. Tetsuro Watabe says, “The EMRECs established in our study can be used for multiple purposes, such as for evaluating the dynamics and distribution of EndoMT in pathological conditions, studying the efficacy of therapeutic agents by live imaging, and screening novel therapeutic drugs targeting each EndoMT stage.”

On the whole, these findings improve our understanding of the mechanisms underlying EndoMT, paving the way for novel therapeutic strategies that target EndoMT-mediated cancer progression and metastases. 

###

The article, “CD40 is expressed in the subsets of endothelial cells undergoing partial EndoMT in tumor microenvironment,” was published in Cancer Science at DOI: 10.1111/cas.16045
 

END


[Attachments] See images for this press release:
Towards a better understanding of endothelial cell transformation in cancer progression Towards a better understanding of endothelial cell transformation in cancer progression 2 Towards a better understanding of endothelial cell transformation in cancer progression 3

ELSE PRESS RELEASES FROM THIS DATE:

After prison, perpetrators of genocide say they’ve changed

2024-02-07
COLUMBUS, Ohio – After serving decades in prison, Rwandans convicted of crimes of genocide returned to their communities articulating a “narrative of redemption,” saying they were good people, despite their past crimes.   And they were hopeful about their prospects for reintegrating into their communities.   Many of these former prisoners had been convicted of murder, often of their own neighbors, connected to the 1994 genocide in Rwanda. But they said they had changed – even while minimizing their role in the killings.   In ...

Japan's electric vehicle transition by 2035 may be insufficient to combat the climate crisis, but there are solutions

Japans electric vehicle transition by 2035 may be insufficient to combat the climate crisis, but there are solutions
2024-02-07
Fukuoka, Japan—Researchers at Kyushu University have found that Japan's current policy of stopping the sale of gas vehicles by 2035 and transitioning only to hybrids and electric vehicles may be insufficient to reduce the country's CO2 emissions and prevent it from reaching its decarbonization target goals. In fact, emissions may temporarily increase. The team's analysis showed that along with the policy, the Japanese government must simultaneously work to increase production of clean ...

From the research bench to the patient’s bedside: Project on Medical Microwave Imaging awarded with 1.5M€

From the research bench to the patient’s bedside: Project on Medical Microwave Imaging awarded with 1.5M€
2024-02-07
The European project entitled “Bone, Brain, Breast and Axillary Medical Microwave Imaging Twinning (3BAtwin)” has been awarded with €1.5M to reinforce our training on Medical Microwave Imaging (MMWI). The project is led by the Faculty of Sciences of the University of Lisbon (Ciências ULisboa) (Portugal), in collaboration with University of Galway (Ireland) and Turin Polytechnic University (Italy). The goal of this twinning project is to accelerate the transition of Medical Microwave Imaging “from the research bench ...

New resource for selecting best treatment path for young children with cancerous tumors published by NCCN

New resource for selecting best treatment path for young children with cancerous tumors published by NCCN
2024-02-07
PLYMOUTH MEETING, PA [February 7, 2024] — The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—today published its first ever set of treatment recommendations pertaining to neuroblastoma. Neuroblastoma is a type of solid tumor cancer that typically occurs in early childhood, with the majority diagnosed before age five.[1] Neuroblastoma is the most common type of solid tumor (outside of brain tumors) in children, with more than 700 cases diagnosed in the United States every year.[2] Research innovations ...

Gut microbiome changes during pregnancy may influence immune system response

2024-02-07
Highlights: Alterations in gut microbiota may influence immune system changes during pregnancy. However, the connection isn’t well known. Researchers in China analyzed gut microbiota, metabolites and cytokines in healthy pregnant and non-pregnant young women. The new study identifies numerous pathways by which the gut microbiome may change the immune system. Washington, D.C.—During pregnancy, a woman’s immune system changes dramatically but researchers don’t yet understand all the underlying mechanisms. A new study shows how the gut microbiota may play a role. In a paper published this week in mSystems, researchers in China report that during pregnancy, ...

Warmer water may help rivers keep antimicrobial resistance at bay

2024-02-07
Highlights: Wastewater, even when treated, can deliver antimicrobial resistance genes to rivers. Further research is needed on if rivers function as a protective barrier. Researchers subjected biofilms from pristine rivers to wastewater. Antibiotic resistant bacteria from wastewater successfully integrated at first, but in the warmest water were edged out by naturally occurring microbes. The study suggests that temperature can influence the microbial competition in rivers. Washington, D.C.—Antimicrobial resistant genes (ARGs) from wastewater can end up in natural biofilms in rivers, but they may not stick around very long. This week in mSphere, ...

AIM-HI Accelerator Fund celebrates Yiviva's milestone collaboration with AstraZeneca China, furthering technology platforms for multiple cancers

AIM-HI Accelerator Fund celebrates Yivivas milestone collaboration with AstraZeneca China, furthering technology platforms for multiple cancers
2024-02-07
Accelerating Innovation in Medicine - Health Initiative (AIM-HI) is proud to celebrate a significant milestone in the journey of one of its esteemed portfolio companies, Yiviva. A clinical-stage platform biotechnology company, Yiviva has entered into a Memorandum of Understanding (MOU) with AstraZeneca China, a multinational biopharmaceutical leader. AIM-HI exists to support bold new ideas in treating and preventing cancer. So when Yale Professor Yung-Chi Cheng approached us years ago about mining ancient Chinese herbs for modern therapies, we took notice. Other investors ...

New scientific research will test PREVENT risk calculator among diverse groups

2024-02-07
DALLAS, Feb. 7, 2024 — Research teams from Northwestern University Feinberg School of Medicine, New York University and Duke University will work together to assess the accuracy of the American Heart Association’s new PREVENTTM risk calculator with funding from the Association’s De-biasing Clinical Care Algorithms project. The American Heart Association, celebrating 100 years of service in 2024, is­ the single largest non-government supporter of heart and brain health research in the U.S. The de-biasing project is funded by a grant from the Doris Duke Foundation to study the role of race and ethnicity in clinical equations and their ...

Does your community have a personality type?

Does your community have a personality type?
2024-02-07
Geographic sorting along ideological lines is on the rise. Counties and regions of the United States differ in political ideology. But do they differ in personality as well? Further, are people who ‘fit’ their communities healthier, happier, or more highly achieving than those who do not? In the context of these growing divisions and to address this question, a study by Florida Atlantic University’s Kevin Lanning, Ph.D., senior author and a professor of psychology and data science in the Harriet L. Wilkes Honors College on FAU’s John D. MacArthur Campus in Jupiter, and ...

MXene-coated devices can guide microwaves in space and lighten the payload

MXene-coated devices can guide microwaves in space and lighten the payload
2024-02-07
One of the most important components of satellites that enable telecommunication is the waveguide, which is a metal tube for guiding radio waves. It is also one of the heaviest payloads satellites carry into orbit. As with all space technology, reducing weight means reducing the amount of expensive and greenhouse gas-producing fuel it takes to launch a rocket, or increasing the number of devices carried by the same rocket to space. Researchers from Drexel University and the University of British Columbia are trying to lighten the load by creating and testing a waveguide made ...

LAST 30 PRESS RELEASES:

Rugged Falklands landscape was once a lush rainforest

Dizziness in older adults is linked to higher risk of future falls

Triptans more effective than newer, more expensive migraine drugs

Iron given through the vein corrects iron deficiency anaemia in pregnant women faster and better than iron taken by mouth

The Lancet Neurology: Air pollution, high temperatures, and metabolic risk factors driving global increases in stroke, with latest figures estimating 12 million cases and over 7 million deaths from st

Incidence of neuroleptic malignant syndrome during antipsychotic treatment in children and youth

Levels of protection from different cycle helmets revealed by new ratings

Pupils with SEND continue to fall behind their peers

Half of heavier drinkers say calorie labels on alcohol would lead to a change in their drinking habits

Study first to link operating room design to shorter surgery

New study uncovers therapeutic inertia in the treatment of women with multiple sclerosis

Cancer Cooperative Group leaders propose a re-engineering of the nation’s correlative science program for cancer

Nawaz named ASME Fellow

U2opia signs license to commercialize anomaly-detection technology for cybersecurity

Explaining dramatic planetwide changes after world’s last ‘Snowball Earth’ event

Cleveland Clinic study is first to show success in treating rare blood disorder

Bone marrow cancer drug shows success in treatment of rare blood disorder

Clinical trial successfully repurposes cancer drug for hereditary bleeding disorder

UVA Engineering professor awarded $1.6M EPA grant to reduce PFAS accumulation in crops

UVA professor receives OpenAI grant to inform next-generation AI systems

New website helps researchers overcome peer reviewers’ preference for animal experiments

Can the MIND diet lower the risk of memory problems later in life?

Some diabetes drugs tied to lower risk of dementia, Parkinson’s disease

Propagated corals reveal increased resistance to bleaching across the Caribbean during the fatal heatwave of 2023

South African rock art possibly inspired by long-extinct species

Even marine animals in untouched habitats are at risk from human impacts

Hexagonal electrohydraulic modules shape-shift into versatile robots

Flexible circuits made with silk and graphene on the horizon

Scott Emr and Wesley Sundquist awarded 2024 Horwitz Prize for discovering the ESCRT pathway

Versatile knee exo for safer lifting

[Press-News.org] Towards a better understanding of endothelial cell transformation in cancer progression